Treatment increases CD69+ and - IFNγ+ and - NK cell populations in the uterus during infection (Figs. 5B–F and EV4C,D) but does not increase the numbers of mature NK cells systemicly (Fig. 5G). This evidence concerns the gene CD69 and infection.